文献速递脑血管病神经重症与神经感染

血栓中性粒细胞胞外诱捕网含量损害急性缺血性卒中tPA诱导的溶栓

Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2018-02-08

该研究分析108例接受血管内治疗的急性缺血性卒中患者血栓,发现中性粒细胞胞外诱捕网(NETs)参与所有血栓构成,其含量与血管内治疗操作时长和器械通过次数显著相关,但不与临床结局或病因相关。体外实验显示重组DNA酶1可加速tPA诱导的溶栓,而单用DNA酶1无效。作者认为血栓NETs含量可能导致再灌注抵抗,无论病因如何,并建议探索DNA酶1联合tPA的策略。

要点

  • NETs参与所有急性缺血性卒中血栓的构成,尤其在外层。
  • 血栓NETs含量与血管内治疗操作时长和器械通过次数显著相关。
  • 体外重组DNA酶1加速tPA诱导的溶栓,单用DNA酶1无效。

核心结论

  • 本研究提示血栓NETs含量可能导致再灌注抵抗,包括对静脉tPA的机械或药物途径抵抗,无论其病因如何。
  • 作者认为应在急性缺血性卒中背景下探索DNA酶1联合tPA给药的策略。

研究设计与样本

  • 研究分析了108例接受血管内治疗的急性缺血性卒中患者的血栓。
  • 血栓通过苏木精/伊红染色、免疫染色和体外酶学试验进行表征。
  • 体外评估了脱氧核糖核酸酶1(DNA酶1)对急性缺血性卒中血栓溶栓的影响。
  • 临床试验注册号:NCT02907736。

主要发现

  • 组织学分析显示NETs参与所有急性缺血性卒中血栓的构成,尤其在外层。
  • 血栓NETs含量的定量测量与临床结局或急性缺血性卒中发病机制无关,但与血管内治疗操作时长和器械通过次数显著相关。
  • 体外重组DNA酶1加速tPA诱导的溶栓,而单用DNA酶1无效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Neutrophil Extracellular Traps (NETs) are DNA extracellular networks decorated with histones and granular proteins produced by activated neutrophils. NETs have been identified as major triggers and structural factors of thrombosis. A recent study designated extracellular DNA threads from NETs as a potential therapeutic target for improving tissue-type plasminogen activator (tPA)-induced thrombolysis in acute coronary syndrome. The aim of this study was to assess the presence of NETs in thrombi retrieved during endovascular therapy in patients with acute ischemic stroke (AIS) and their impact on tPA-induced thrombolysis. METHODS: We analyzed thrombi from 108 AIS patients treated with endovascular therapy. Thrombi were characterized by hematoxylin/eosin staining, immunostaining, and ex vivo enzymatic assay. Additionally, we assessed ex vivo the impact of deoxyribonuclease 1 (DNAse 1) on thrombolysis of AIS thrombi. RESULTS: Histological analysis revealed that NETs contributed to the composition of all AIS thrombi especially in their outer layers. Quantitative measurement of thrombus NETs content was not associated with clinical outcome or AIS pathogenesis but correlated significantly with endovascular therapy procedure length and device number of passes. Ex vivo, recombinant DNAse 1 accelerated tPA-induced thrombolysis, whereas DNAse 1 alone was ineffective. CONCLUSIONS: This study suggests that thrombus NETs content may be responsible for reperfusion resistance, including mechanical or pharmacological approaches with intravenous tPA, irrespectively of their etiology. The efficacy of a strategy involving an administration of DNAse 1 in addition to tPA should be explored in the setting of AIS. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02907736.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ducroux C, Di Meglio L, Loyau S, et al. Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke. Stroke. 2018. PMID: 29438080. doi:10.1161/STROKEAHA.117.019896

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。